Docs should consider a patient’s weight before prescribing new chemotherapy drugs

A new class of cancer drugs just now entering the marketplace seems promising so far, but researchers at the University of Illinois at Chicago - led by University of Illinois Cancer Center member Paul Grippo - urge doctors to take into account a patient’s weight and liver status before prescribing them. The drugs are known as PI3K inhibitors, and they dramatically decrease the activation of a pathway commonly used by cancer cells to…

Continue Reading

Slate of cancer experts set for Distinguished Lecture Series

The lineup for the University of Illinois Cancer Center’s Distinguished Lecture Series has been set, and it’s full of “heavy hitters.” Douglas Lowy, MD, acting director of the National Cancer Institute of the National Institutes of Health (NIH) and deputy director of NCI since 2010, will kick-off the series on Monday, July 15, as he will present “Preventing Cervical Cancer and Other HPV-associated Cancers by Vaccination and Screening.” The presentation will be held…

Continue Reading

Pauli recognized as UIC Distinguished Professor

University of Illinois Cancer Center member Guido Pauli, PhD, received the honorary title of UIC Distinguished Professor for the 2019-2020 academic year in the UIC College of Pharmacy. The designation was created to recognize faculty who have made significant impacts through scholarship, creativity and leadership. Pauli is a Norman. R. Farnsworth Professor of Pharmacognosy, associate director of the Institute for Tuberculosis Research, and director of the Program for Collaborative Research in the Pharmaceutical…

Continue Reading

Smoking age in Illinois rises

As of July 1, it is illegal for individuals under the age of 21 in Illinois to purchase cigarettes, e-cigarettes and other tobacco products. Illinois is one of 14 states that have raised the smoking age to 21. Gov. J.B. Pritzker signed HB345, an initiative known as Tobacco 21, on April 7. In 2018, U.S. Surgeon General Jerome Adams, MD, said e-cigarette use among young people was increasing at a rate of “epidemic…

Continue Reading

Newly activated UI Cancer Center Clinical Trials

The following study has recently been activated for patient enrollment by the University of Illinois Cancer Center Clinical Trials Office (CTO). Please click on the link to learn about the details regarding the study on clinicaltrials.gov. For more information or questions about a study, please email cancertrials@uic.edu or call 312-355-5112. Phase III Randomized Study of Crenolanib versus Midostaurin Administered Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed Subjects with FLT3 Mutated Acute…

Continue Reading